RaySearch Laboratories AB (publ)
RSLBF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $1,192,029 | $1,022,159 | $843,648 | $641,673 |
| % Growth | 16.6% | 21.2% | 31.5% | – |
| Cost of Goods Sold | $99,492 | $106,578 | $94,991 | $50,397 |
| Gross Profit | $1,092,537 | $915,581 | $748,657 | $591,276 |
| % Margin | 91.7% | 89.6% | 88.7% | 92.1% |
| R&D Expenses | $269,384 | $237,736 | $238,769 | $233,443 |
| G&A Expenses | $249,585 | $195,163 | $171,719 | $122,036 |
| SG&A Expenses | $576,170 | $558,009 | $481,143 | $422,228 |
| Sales & Mktg Exp. | $326,585 | $362,846 | $309,424 | $300,192 |
| Other Operating Expenses | -$13,510 | $4,956 | -$1,562 | -$353 |
| Operating Expenses | $832,044 | $800,701 | $718,350 | $655,318 |
| Operating Income | $260,493 | $114,880 | $42,744 | -$52,637 |
| % Margin | 21.9% | 11.2% | 5.1% | -8.2% |
| Other Income/Exp. Net | $2,372 | -$4,792 | -$10,369 | -$5,332 |
| Pre-Tax Income | $262,865 | $110,088 | $32,375 | -$58,673 |
| Tax Expense | $59,352 | $28,516 | $8,597 | -$11,358 |
| Net Income | $203,513 | $81,572 | $23,778 | -$47,315 |
| % Margin | 17.1% | 8% | 2.8% | -7.4% |
| EPS | 5.94 | 2.38 | 0.69 | -1.38 |
| % Growth | 149.6% | 244.9% | 150% | – |
| EPS Diluted | 5.94 | 2.38 | 0.69 | -1.38 |
| Weighted Avg Shares Out | 34,261 | 34,283 | 34,283 | 34,283 |
| Weighted Avg Shares Out Dil | 34,261 | 34,283 | 34,283 | 34,283 |
| Supplemental Information | – | – | – | – |
| Interest Income | $11,418 | $4,895 | $1,109 | $708 |
| Interest Expense | $8,987 | $9,687 | $11,478 | $6,036 |
| Depreciation & Amortization | $299,378 | $286,154 | $296,994 | $250,000 |
| EBITDA | $571,230 | $405,929 | $340,847 | $197,362 |
| % Margin | 47.9% | 39.7% | 40.4% | 30.8% |